Screening programs play a vital role in reducing cancer mortality by enabling early detection. Population-based screening for cancers such as breast, cervical, and colorectal has demonstrated significant public health benefits. Innovations in screening technologies, such as low-dose CT scans for lung cancer and HPV testing for cervical cancer, are improving diagnostic accuracy. Research emphasizes the development of cost-effective and culturally appropriate screening strategies to enhance accessibility in underserved populations. The integration of AI in screening workflows further refines early detection, contributing to better patient outcomes.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States